Nuvectis Historical Cash Flow
| NVCT Stock | USD 5.04 0.24 4.55% |
Analysis of Nuvectis Pharma cash flow over time is an excellent tool to project Nuvectis Pharma future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Financing Activities of 20.2 M or End Period Cash Flow of 12.3 M as it is a great indicator of Nuvectis Pharma ability to facilitate future growth, repay debt on time or pay out dividends.
Nuvectis |
About Nuvectis Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Nuvectis balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Nuvectis's non-liquid assets can be easily converted into cash.
Nuvectis Pharma Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Most accounts from Nuvectis Pharma's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Nuvectis Pharma current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvectis Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Nuvectis Stock please use our How to Invest in Nuvectis Pharma guide.At this time, Nuvectis Pharma's Change In Working Capital is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 5 M in 2024, despite the fact that Change In Cash is likely to grow to (823.6 K).
| 2022 | 2023 | 2024 (projected) | Change To Liabilities | 4.1M | 4.8M | 5.0M | Change To Netincome | 1.7M | 1.5M | 1.5M |
Nuvectis Pharma cash flow statement Correlations
Click cells to compare fundamentals
Nuvectis Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nuvectis Stock Analysis
When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.